Search results
Results From The WOW.Com Content Network
Alcon Inc. Alcon Inc. ( German: Alcon AG) is a Swiss-American pharmaceutical and medical device company specializing in eye care products. It has a paper headquarters in Geneva, Switzerland but its operational headquarters are in Fort Worth, Texas, United States, where it employs about 4,500 people. [2]
The master limited partnership (MLP) has delivered 25 consecutive years of distribution growth, raising its payout at a 7% compound annual rate. Dividend growth tends to drive long-term ...
Between the company's shrinking business in 2023 and the current high dividend yield, skeptical investors may balk at buying shares, fearing that the company's financial health is in jeopardy.
The total cost to Novartis for the 77% stake in Alcon was $38.7 billion ($168 per share). In the deal's first phase, Novartis acquired a 25% stake in Alcon from Nestlé for $10.4 billion in July 2008.
Novartis. / 47.5744252; 7.5764914. Pharmaceutical drugs, generic drugs, over-the-counter drugs, vaccines, diagnostics, contact lenses, animal health ( list...) Novartis AG is a Swiss multinational pharmaceutical corporation based in Basel, Switzerland. Consistently ranked in the global top five, Novartis is one of the largest pharmaceutical ...
This is a list of notable Singaporean exchange-traded funds, or ETFs . ABF Singapore Bond Index Fund. CIMB FTSE ASEAN40 ETF. CIMB S&P Ethical Asia Pacific Dividend ETF. db x-trackers CSI300 UCITS ETF. db x-trackers DB Commodity Booster Bloomberg UCITS ETF. db x-trackers DB Commodity Booster Light Energy Benchmark UCITS ETF.
Aerie Pharmaceuticals Inc. is a clinical-stage pharmaceutical company focused on the discovery, development and commercialization of therapies for the treatment of patients with glaucoma and other diseases of the eye. Aerie's two lead product candidates are once-daily therapies for lowering intraocular pressure with mechanisms to treat patients ...
The Zyn brand holds a dominant position in the nascent nicotine pouch category, with an estimated 75% volume share in the United States. Now, with many customers unable to get their nicotine fixes ...